Top news of the day: More people will have access to ACA plans with no premiums, a challenge to Arizona's Medicaid expansion funding goes to the state supreme court, and a dive into coverage of the opioid epidemic.
The decision by President Donald Trump to cut off the cost-sharing subsidies to insurers may actually help the Affordable Care Act (ACA). According to The Wall Street Journal, ending the insurer subsidies actually increased consumer subsidies and the number of people who can buy an ACA plan with no premium. Insurers are expected to promote the no-premium plans to draw in more enrollees.A challenge to the funding mechanism for Arizona’s Medicaid expansion plan has reached the state’s supreme court. Republicans who brought the lawsuit argued that the hospital assessment fee that helps pay for the expansion plan, reported AP. Arizona’s Medicaid expansion program covers 400,000 residents, and the whole Medicaid plan covers 1.9 million Arizona adults. The court hasn’t indicated when it would issue a ruling.With the president declaring the opioid epidemic a public health emergency, The New York Times has provided a look at its ongoing reporting of the crisis. The coverage includes how toddlers and young children have also been affected, a dive into the data on overdose deaths from 1999 to 2014, and treating inmates who are recovering addicts.
Review Emphasizes Potential Infection Risks With BTK Inhibitors
November 2nd 2024Although Bruton tyrosine kinase (BTK) inhibitor monotherapy in chronic lymphocytic leukemia (CLL) has been a game-changer, patients have significantly increased risks of infection, especially in the upper respiratory tract.
Read More
Sustaining Compassionate Trauma Care Across Communities
September 30th 2024September is National Recovery Month, and we are bringing you another limited-edition month-long podcast series with our Strategic Alliance Partner, UPMC Health Plan. In our final episode, we speak with Lyndra Bills, MD, and Shari Hutchison, MS.
Listen
PAH Treatment Outcomes Similar Regardless of Diagnosis Time
November 1st 2024The study findings underscore the importance of early initiation of macitentan and tadalafil among patients who have pulmonary arterial hypertension (PAH), and represent a shift in understanding of prognosis based on diagnosis timing.
Read More
Review Emphasizes Potential Infection Risks With BTK Inhibitors
November 2nd 2024Although Bruton tyrosine kinase (BTK) inhibitor monotherapy in chronic lymphocytic leukemia (CLL) has been a game-changer, patients have significantly increased risks of infection, especially in the upper respiratory tract.
Read More
Sustaining Compassionate Trauma Care Across Communities
September 30th 2024September is National Recovery Month, and we are bringing you another limited-edition month-long podcast series with our Strategic Alliance Partner, UPMC Health Plan. In our final episode, we speak with Lyndra Bills, MD, and Shari Hutchison, MS.
Listen
PAH Treatment Outcomes Similar Regardless of Diagnosis Time
November 1st 2024The study findings underscore the importance of early initiation of macitentan and tadalafil among patients who have pulmonary arterial hypertension (PAH), and represent a shift in understanding of prognosis based on diagnosis timing.
Read More
2 Commerce Drive
Cranbury, NJ 08512